Common Contracts
2 similar Retention Bonus Letter contracts by ARCA Biopharma, Inc.
ARCA BIOPHARMA, INC. SECOND AMENDMENT TO RETENTION BONUS LETTERRetention Bonus Letter • April 23rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This second amendment (this “Amendment”) is entered into effective as of April 22, 2024 by and between Thomas A. Keuer (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).
ARCA BIOPHARMA, INC. SECOND AMENDMENT TO RETENTION BONUS LETTERRetention Bonus Letter • April 23rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This second amendment (this “Amendment”) is entered into effective as of April 22, 2024 by and between C. Jeffrey Dekker (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).
